Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit

NCT04700202 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT04700202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04700202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Completed
Start date
June 30, 2020
Completion date
December 15, 2022
Enrollment
132 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hospital-acquired pneumonia, ventilator-associated pneumonia